Science
Neuroproteins are potential diagnostic tool for sick foals
Publication: Phys.org - latest science and technology news stories
Author: Not available in collected metadata
Source published: 28/09/2026, 17:40:06 UTC
Briefing created: 28/09/2026, 18:08:32 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 28/09/2026, 17:55:25 UTC.
Briefings
Researchers from North Carolina State University identified that elevated blood serum levels of neuroproteins and neurosteroids correlate with neonatal maladjustment syndrome (NMS) in newborn foals. This study suggests these biomarkers could serve as diagnostic tools and potential therapeutic targets for improving outcomes in sick foals.
Key points
- Neonatal maladjustment syndrome (NMS) in newborn foals is associated with elevated blood serum concentrations of neuroproteins and neurosteroids.
- The study indicates that monitoring these specific biomarkers in foals may aid in diagnosing NMS and developing targeted therapies.
Context and limitations
This research is based on a single study from 2026. Results are preliminary and may vary across different populations or clinical settings.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 28/09/2026, 18:08:32 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeifw4fme5p5b6hoqbsewg3td7b3bg7nzhr4xswjtnk6bycvu7iqgu4